Quanta Inc (fka QNTA)

[falon]

Results from first Toxicology test:

The study, which was completed through a third-party contract research organization (CRO) located in California under strict medical guidelines, was conducted in two phases on BALB/c mice. The first phase was completed on 12 mice where the mice were given the drug candidate at a 26 µg/kg dose volume and monitored for 24 hours. At the conclusion of the first phase, researchers did not observe any significant abnormalities. In the second phase, the same dose of the drug candidate was administered daily over the course of 14 days where researchers also observed no significant abnormalities in clinical observations, body weight, necropsy observation, hematology, and clinical chemistry. These observations rendered a study result that the candidate is well-tolerated in mice and thus is proven safe and non-toxic.https://ir.quantrx.com/news-events/press-releases/detail/50/medolife-rx-announces-preclinical-trial-results-from

The test only took a few weeks and was done by a CRO.
I suspect this next test will be done by a CRO and should be done and complete by the end of July if not sooner.